Immuneering Corporation (IMRX)
NASDAQ
Market Cap
$40.92M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
170 of 809
Rank in Industry
109 of 445
Largest Insider Buys in Sector
IMRX Stock Price History Chart
IMRX Stock Performance
About Immuneering Corporation
Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to treat solid tumors. The company also has five oncology programs in the discovery stage that are designed to target components of the MAPK or mTOR pathway; and two discovery stage neuroscience programs. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts. Immuneering Corporation was a former subsidiary of Teva Pharmaceutical Industries Limited.
Insider Activity of Immuneering Corporation
Over the last 12 months, insiders at Immuneering Corporation have bought $477,955 and sold $3.91M worth of Immuneering Corporation stock.
On average, over the past 5 years, insiders at Immuneering Corporation have bought $9.38M and sold $3.91M worth of stock each year.
Highest buying activity among insiders over the last 12 months: BERMAN ANN E (director) — $246,873. Feinberg Peter (director) — $246,771. Zeskind Benjamin J. (PRESIDENT AND CEO) — $55,326.
The last purchase of 25,000 shares for transaction amount of $63,713 was made by Feinberg Peter (director) on 2024‑03‑22.
List of Insider Buy and Sell Transactions, Immuneering Corporation
| 2024-04-01 | Sale | Cormorant Asset Management, LP | 10 percent owner | 400,000 1.4407% | $2.90 | $1.16M | -44.00% | |
| 2024-03-22 | Feinberg Peter | director | 25,000 0.0853% | $2.55 | $63,713 | -39.22% | ||
| 2024-03-22 | Morales Mallory | Chief Accounting Officer | 393 0.0013% | $2.55 | $1,000 | -39.22% | ||
| 2024-03-22 | Brakewood Harold Eugene | Chief Business Officer | 3,900 0.0134% | $2.57 | $10,015 | -39.22% | ||
| 2024-03-22 | Schall Thomas J. | director | 2,900 0.0099% | $2.55 | $7,385 | -39.22% | ||
| 2024-03-21 | Morales Mallory | Chief Accounting Officer | 1,107 0.0038% | $2.72 | $3,009 | -43.07% | ||
| 2024-03-20 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 7,000 0.0246% | $2.86 | $20,020 | -43.88% | ||
| 2024-03-20 | Neufeld Leah R | CHIEF PEOPLE OFFICER | 3,818 0.0135% | $2.88 | $10,993 | -43.88% | ||
| 2024-03-19 | Zeskind Benjamin J. | PRESIDENT AND CEO | 20,000 0.0735% | $2.77 | $55,326 | -39.06% | ||
| 2024-03-19 | Feinberg Peter | director | 25,000 0.085% | $2.56 | $64,000 | -39.06% | ||
| 2024-03-18 | BERMAN ANN E | director | 57,965 0.1647% | $2.13 | $123,436 | -39.06% | ||
| 2024-03-18 | Feinberg Peter | director | 50,000 0.1588% | $2.38 | $119,058 | -39.06% | ||
| 2024-03-15 | Sale | Cormorant Asset Management, LP | 10 percent owner | 400,000 1.5312% | $2.14 | $856,400 | -18.32% | |
| 2024-03-14 | Sale | Cormorant Asset Management, LP | 10 percent owner | 509,091 1.0954% | $3.72 | $1.89M | -46.21% | |
| 2022-05-25 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 2,551 0.0097% | $3.92 | $10,000 | +74.81% | ||
| 2022-05-17 | Bookman Michael | GENERAL COUNSEL AND SECRETARY | 1,000 0.0037% | $4.88 | $4,880 | +32.61% | ||
| 2022-05-16 | KEATING LAURIE | 7,000 0.0283% | $5.00 | $35,000 | +42.64% | |||
| 2022-05-12 | Amin Biren | CFO, TREASURER | 1,000 0.0033% | $4.42 | $4,420 | +31.29% | ||
| 2022-03-23 | Zeskind Benjamin J. | PRESIDENT AND CEO | 3,000 0.0119% | $8.02 | $24,060 | -18.85% | ||
| 2022-03-23 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 1,050 0.0041% | $7.91 | $8,306 | -18.85% |
Insider Historical Profitability
<0.0001%
| Zeskind Benjamin J. | PRESIDENT AND CEO | 2281852 7.7124% | $1.38 | 4 | 0 | <0.0001% |
| Cormorant Asset Management, LP | 2895273 7.6963% | $1.38 | 1 | 3 | <0.0001% | |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | 345896 1.1366% | $1.38 | 4 | 0 | +2.71% |
| Feinberg Peter | 111766 0.0402% | $1.38 | 7 | 0 | <0.0001% | |
| Neufeld Leah R | CHIEF PEOPLE OFFICER | 10029 0.0342% | $1.38 | 1 | 0 | |
| BERMAN ANN E | 67465 0.0325% | $1.38 | 3 | 0 | <0.0001% | |
| Morales Mallory | Chief Accounting Officer | 8278 0.0283% | $1.38 | 2 | 0 | |
| Brakewood Harold Eugene | Chief Business Officer | 3900 0.0133% | $1.38 | 1 | 0 | |
| Schall Thomas J. | director | 2900 0.0099% | $1.38 | 1 | 0 | |
| CARPENTER ROBERT J | director | 1148839 3.9251% | $1.38 | 1 | 0 | <0.0001% |
| KEATING LAURIE | 14000 0.0478% | $1.38 | 2 | 0 | <0.0001% | |
| Amin Biren | CFO, TREASURER | 7898 0.027% | $1.38 | 2 | 0 | <0.0001% |
| Barrett Scott | CHIEF MEDICAL OFFICER | 7563 0.0258% | $1.38 | 2 | 0 | <0.0001% |
| Bookman Michael | GENERAL COUNSEL AND SECRETARY | 2402 0.0082% | $1.38 | 2 | 0 | <0.0001% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Cormorant Asset Management Lp | $9.52M | 11.11 | 3.3M | -21.62% | -$2.63M | 0.45 | |
| Citadel Advisors LLC | $5.44M | 6.35 | 1.88M | -9.43% | -$566,127.88 | <0.01 | |
| BlackRock | $3.98M | 4.64 | 1.38M | -34.34% | -$2.08M | <0.0001 | |
| The Vanguard Group | $3.48M | 4.06 | 1.2M | +12.09% | +$375,269.42 | <0.0001 | |
| T. Rowe Price | $2.63M | 3.07 | 910,266 | -73.05% | -$7.14M | <0.0001 | |
| Geode Capital Management | $1.34M | 1.56 | 462,520 | +4.12% | +$52,855.61 | <0.0001 | |
| Goldman Sachs | $1.31M | 1.53 | 454,233 | -0.62% | -$8,167.14 | <0.0001 | |
| State Street | $1.09M | 1.27 | 376,896 | +0.86% | +$9,346.26 | <0.0001 | |
| HighVista Strategies | $735,543.00 | 0.86 | 254,513 | 0% | +$0 | 0.27 | |
| Fidelity Investments | $673,942.00 | 0.79 | 233,198 | -52.35% | -$740,559.37 | <0.0001 | |
| Northern Trust | $508,654.00 | 0.59 | 176,005 | -4.31% | -$22,894.56 | <0.0001 | |
| Td Asset Management Inc | $436,032.00 | 0.51 | 150,876 | -23.75% | -$135,830.11 | <0.0001 | |
| Bridgeway Capital Management | $329,602.00 | 0.39 | 114,049 | +192.07% | +$216,750.26 | 0.01 | |
| Exchange Traded Concepts, LLC | $283,954.00 | 0.33 | 98,254 | +464.16% | +$233,621.77 | 0.01 | |
| Southport Management L L C | $260,389.00 | 0.3 | 90,100 | +258.96% | +$187,850.00 | 1.04 | |
| The Manufacturers Life Insurance Company | $252,366.00 | 0.29 | 87,324 | -4.23% | -$11,149.60 | <0.0001 | |
| Millennium Management LLC | $182,827.00 | 0.21 | 63,262 | +453.09% | +$149,771.21 | <0.0001 | |
| Charles Schwab | $174,880.00 | 0.2 | 60,512 | 0% | +$0 | <0.0001 | |
| BNY Mellon | $155,419.00 | 0.18 | 53,778 | -16.01% | -$29,625.50 | <0.0001 | |
| Adage Capital Partners Gp L L C | $144,500.00 | 0.17 | 50,000 | -50% | -$144,500.00 | <0.0001 | |
| Morgan Stanley | $131,838.00 | 0.15 | 45,619 | -18.75% | -$30,428.60 | <0.0001 | |
| Nuveen | $127,301.00 | 0.15 | 44,049 | 0% | +$0 | <0.0001 | |
| Ci Private Wealth Llc | $125,339.00 | 0.15 | 43,370 | +47.67% | +$40,459.90 | <0.0001 | |
| First Manhattan Co. | $96,092.00 | 0.11 | 33,250 | New | +$96,092.00 | <0.0001 | |
| Dimensional Fund Advisors | $90,598.00 | 0.11 | 31,349 | +87.9% | +$42,381.57 | <0.0001 | |
| UBS | $83,669.00 | 0.1 | 28,951 | New | +$83,669.00 | <0.0001 | |
| Corton Capital Inc | $76,689.00 | 0.09 | 26,536 | -1.55% | -$1,210.91 | 0.03 | |
| Barclays | $75,000.00 | 0.09 | 25,793 | -26.14% | -$26,547.90 | <0.0001 | |
| Xtx Topco Ltd | $71,918.00 | 0.08 | 24,885 | New | +$71,918.00 | <0.01 | |
| RhumbLine Advisers | $60,485.00 | 0.07 | 20,932 | +4.54% | +$2,626.64 | <0.0001 | |
| PNC Financial Services | $57,800.00 | 0.07 | 20,000 | 0% | +$0 | <0.0001 | |
| Janney Montgomery Scott LLC | $46,000.00 | 0.05 | 16,055 | -20.32% | -$11,732.79 | <0.0001 | |
| Jane Street Capital | $38,836.00 | 0.05 | 13,438 | New | +$38,836.00 | <0.0001 | |
| Bank of America | $37,578.00 | 0.04 | 13,003 | -46.72% | -$32,948.30 | <0.0001 | |
| American Century Investments | $33,310.00 | 0.04 | 11,526 | -1.18% | -$395.93 | <0.0001 | |
| Deutsche Bank | $32,894.00 | 0.04 | 11,382 | -3.9% | -$1,335.18 | <0.0001 | |
| American International Group | $31,888.00 | 0.04 | 11,034 | -0.84% | -$271.66 | <0.0001 | |
| New York State Common Retirement Fund | $28,000.00 | 0.03 | 9,669 | +6.31% | +$1,662.22 | <0.0001 | |
| JPMorgan Chase | $26,845.00 | 0.03 | 9,289 | -42.21% | -$19,608.50 | <0.0001 | |
| Wells Fargo | $20,155.00 | 0.02 | 6,974 | +15.31% | +$2,676.16 | <0.0001 | |
| Citigroup | $15,861.00 | 0.02 | 5,488 | +45.69% | +$4,973.90 | <0.0001 | |
| Tower Research Capital | $14,141.00 | 0.02 | 4,893 | +123.94% | +$7,826.25 | <0.0001 | |
| CalSTRS | $7,346.00 | 0.01 | 2,542 | -31.02% | -$3,303.10 | <0.0001 | |
| Legal & General | $6,266.00 | 0.01 | 2,168 | 0% | +$0 | <0.0001 | |
| Ameritas Investment Partners Inc | $4,841.00 | 0.01 | 1,675 | 0% | +$0 | <0.0001 | |
| Advisor Group Holdings Inc | $2,890.00 | <0.01 | 1,000 | New | +$2,890.00 | <0.0001 | |
| Royal Bank of Canada | $2,000.00 | <0.01 | 784 | -88.9% | -$16,020.41 | <0.0001 | |
| Amalgamated Bank | $2,000.00 | <0.01 | 684 | -73.8% | -$5,634.50 | <0.0001 | |
| CWM LLC | $0 | <0.01 | 2 | New | +$0 | <0.0001 | |
| Nelson Van Denburg & Campbell Wealth Management Group LLC | $11.00 | <0.01 | 4 | New | +$11.00 | <0.0001 |